Identification and quantitative analysis of physalin D and its metabolites in rat urine and feces by liquid chromatography with triple quadrupole time‐of‐flight mass spectrometry. Issue 11 (3rd May 2017)

• Record Type: Journal Article
• Authors: Zheng, Yunliang; Cao, Cong; Lin, Meihua; Zhai, You; Ge, Zhiwei; ShenTu, Jianzhong; Wu, Lihua; Hu, Xingjiang
• Is Part Of: Journal of separation science. Volume 40:Issue 11(2017)
• Page Start: 2355
• Page End: 2365
• Publication Date: 2017-05-03
• Subjects: excretion study -- metabolite identification -- physalin D -- quantitative analysis; Separation (Technology) -- Periodicals; Chromatographic analysis -- Periodicals; 543.089
• DOI: 10.1002/jssc.201700038
• Languages: English
• ISSNs: 1615-9306

Abstract

Abstract : Physalin D is known to show extensive bioactivities. However, no excretion study has elucidated the excretion of physalin D and its metabolites. This study investigates the excretion of physalin D and its metabolites in rats. Metabolites in rat urine and feces were separated and identified by liquid chromatography with triple quadrupole time‐of‐flight mass spectrometry. Furthermore, a validated high‐performance liquid chromatography with tandem mass spectrometry method was developed to quantify physalin D, physalin D glucuronide, and physalin D sulfate in rat feces and urine after the intragastric administration of physalin D. The analyte showed good linearity over a wide concentration range ( r > 0.995), and the lower limit of quantification was 0.0532 μg/mL and 0.226 μg/g for urine and feces, respectively. Nine metabolites, including five phase I and four phase II metabolites, were identified and clarified after dosing in vivo. Only 4.0% of the gavaged dose, including physalin D and its phase II metabolites, was excreted in urine, whereas 10.8% was found in feces in the unchanged form. The results indicate that the extensive and rapid metabolism may be the main factors leading to the short half‐life of physalin D. These results can provide a basis for further studies on the structural modification and pharmacology of physalin D.